348 related articles for article (PubMed ID: 16779906)
1. [Acute tubulointerstitial nephritis in HIV infection].
Möddel M; Pfammatter R; Varga Z; Keusch G
Praxis (Bern 1994); 2006 Jun; 95(23):949-51. PubMed ID: 16779906
[TBL] [Abstract][Full Text] [Related]
2. Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies.
Schmid S; Opravil M; Moddel M; Huber M; Pfammatter R; Keusch G; Ambuhl P; Wuthrich RP; Moch H; Varga Z
Virchows Arch; 2007 Jun; 450(6):665-70. PubMed ID: 17464512
[TBL] [Abstract][Full Text] [Related]
3. Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.
Viglietti D; Verine J; De Castro N; Scemla A; Daudon M; Glotz D; Pillebout E
Antivir Ther; 2011; 16(1):119-21. PubMed ID: 21311116
[TBL] [Abstract][Full Text] [Related]
4. Acute interstitial nephritis associated with atazanavir, a new protease inhibitor.
Brewster UC; Perazella MA
Am J Kidney Dis; 2004 Nov; 44(5):e81-4. PubMed ID: 15492941
[TBL] [Abstract][Full Text] [Related]
5. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.
Rocha JL; Fernández-Alonso J
Lancet; 2001 Jun; 357(9272):1946-7. PubMed ID: 11425419
[TBL] [Abstract][Full Text] [Related]
6. [Acute and subacute renal failure].
Praxis (Bern 1994); 2008 Oct; 97(20):1057-64; quiz 1065-6. PubMed ID: 18850521
[No Abstract] [Full Text] [Related]
7. Diffuse tubulointerstitial nephritis accompanied by renal crystal formation in an HIV-infected patient undergoing highly active antiretroviral therapy.
Kanzaki G; Tsuboi N; Miyazaki Y; Yokoo T; Utsunomiya Y; Hosoya T
Intern Med; 2012; 51(12):1543-8. PubMed ID: 22728488
[TBL] [Abstract][Full Text] [Related]
8. Kidney biopsy in HIV: beyond HIV-associated nephropathy.
Fine DM; Perazella MA; Lucas GM; Atta MG
Am J Kidney Dis; 2008 Mar; 51(3):504-14. PubMed ID: 18295067
[No Abstract] [Full Text] [Related]
9. Acute interstitial nephritis with predominant plasmacytic infiltration in patients with HIV-1 infection.
Melica G; Matignon M; Desvaux D; Audard V; Copie-Bergman C; Lang P; Levy Y; Grimbert P
Am J Kidney Dis; 2012 May; 59(5):711-4. PubMed ID: 22342319
[TBL] [Abstract][Full Text] [Related]
10. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
[No Abstract] [Full Text] [Related]
11. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy.
Hamada Y; Nishijima T; Watanabe K; Komatsu H; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
Clin Infect Dis; 2012 Nov; 55(9):1262-9. PubMed ID: 22820542
[TBL] [Abstract][Full Text] [Related]
12. Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir.
Van den Eynde E; Ferrer E; Podzamczer D
AIDS; 2014 Jun; 28(10):1538-9. PubMed ID: 24896804
[No Abstract] [Full Text] [Related]
13. Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
Zaidan M; Lescure FX; Brochériou I; Dettwiler S; Guiard-Schmid JB; Pacanowski J; Rondeau E; Pialoux G; Girard PM; Ronco P; Plaisier E
Clin J Am Soc Nephrol; 2013 Jun; 8(6):930-8. PubMed ID: 23430209
[TBL] [Abstract][Full Text] [Related]
14. Acute renal failure in an HIV-positive 50-year-old man.
Krishnan M; Nair R; Haas M; Atta MG
Am J Kidney Dis; 2000 Nov; 36(5):1075-8. PubMed ID: 11054370
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results.
Gatell J; Salmon-Ceron D; Lazzarin A; Van Wijngaerden E; Antunes F; Leen C; Horban A; Wirtz V; Odeshoo L; Van den Dungen M; Gruber C; Ledesma E;
Clin Infect Dis; 2007 Jun; 44(11):1484-92. PubMed ID: 17479947
[TBL] [Abstract][Full Text] [Related]
16. [Calcified].
Gerber L; Gaspert A; Bleisch JA
Praxis (Bern 1994); 2012 May; 101(11):739-42. PubMed ID: 22618699
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin-related acute interstitial nephritis in a patient with pancreatic neuroendocrine tumor.
Asai A; Katsuno T; Yamaguchi M; Iwagaitsu S; Nobata H; Kinashi H; Kitamura H; Banno S; Ito Y
CEN Case Rep; 2020 May; 9(2):114-121. PubMed ID: 31834568
[TBL] [Abstract][Full Text] [Related]
18. [Kidney disease in HIV-infected patient].
Matuszkiewicz-Rowińska J; Wieliczko M
Wiad Lek; 2016; 69(5):725-728. PubMed ID: 28033595
[TBL] [Abstract][Full Text] [Related]
19. Clinical Approach to Diagnosing Acute and Chronic Tubulointerstitial Disease.
Perazella MA
Adv Chronic Kidney Dis; 2017 Mar; 24(2):57-63. PubMed ID: 28284380
[TBL] [Abstract][Full Text] [Related]
20. Reversible acute interstitial nephritis associated with indomethacin.
Green J; Yoffe B; Barzilai D; Better OS
Isr J Med Sci; 1985 Feb; 21(2):142-5. PubMed ID: 3980192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
